11:30 - 12:30 | Zaal 7. Van Rijckevorsel & Ruys Zaal | Session by Janssen
No single company or institution holds all the answers. The external environment is changing and demands the creation of new alliances. We need to work together to advance the very best science and outcomes as healthcare becomes more personalized, with more patient empowerment, higher expectations for quality of life and years of life saved. At a technological level, new solutions are being developed, with a strong focus on data generation, digitalization and real-world evidence. By combining strengths of different partners and working together effectively, innovation can be stimulated to deliver more and better results for patients, healthcare and society in general.
Bart van Zijl Langhout Janssen Strategic Alliances EMEA & Janssen The Netherlands
Robert Vries Hubrecht Organoid Technology
Peter Roevens Janssen Pharmaceutica
Ab Klink VGZ
Elena Fernandez-Kleinlein JLABS EMEA
The audience picked Healthy Mind, Iova and PharmaCytics as their top 3 pitchers and of these the jury chose PharmaCytics as the winner of the Axon Innovation for Health Award.